Vital Science
Vital Science
Charles River
Are we One Shot Away?
21 minutes Posted Mar 15, 2022 at 8:00 am.
0:00
21:51
Download MP3
Show notes

Imagine a gene therapy treatment that gives drug-resistant focal epilepsy patients more control over their seizures and ultimately improve their quality of life?

We sat down with Karin Agerman to discuss this possibility and discovered that her work at Combigene is at the forefront of a novel gene therapy called CG01.

Find out how this single-injection therapy is giving renewed hope to this patient population and learn more about CombiGene’s research into CG01.

SHOW NOTES